Measuring effects on intima-media thickness: an evaluation of rosuvastatin in Chinese subjects with subclinical atherosclerosis—design, rationale, and methodology of the METEOR-China study
Abstract Background The beneficial effect of statins on atherosclerosis and cardiovascular outcomes has been well established. The Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin (METEOR) global study demonstrated that a 2-year orally administered treatment with rosuvastat...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-11-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-020-04741-0 |
id |
doaj-aa86253629b1430781383e2dcdcb5f08 |
---|---|
record_format |
Article |
spelling |
doaj-aa86253629b1430781383e2dcdcb5f082020-11-25T04:10:01ZengBMCTrials1745-62152020-11-0121111110.1186/s13063-020-04741-0Measuring effects on intima-media thickness: an evaluation of rosuvastatin in Chinese subjects with subclinical atherosclerosis—design, rationale, and methodology of the METEOR-China studyYilong Wang0Anxin Wang1Hongwei Li2Zhanquan Li3Bo Hu4Xiaogang Li5Huaguang Zheng6Lu Fu7Hongtao Hu8Zhiyu Nie9Yulin Qin10Bilian Zhao11Di Wei12Björn W. Karlson13Michiel L. Bots14Yundai Chen15Yongjun Wang16Beijing Tian Tan Hospital, Capital Medical UniversityBeijing Tian Tan Hospital, Capital Medical UniversityDepartment of Cardiology, Beijing Friendship Hospital Affiliated to Capital Medical UniversityThe People’s Hospital of Liaoning ProvinceDepartment of Neurology, Union Hospital of Huazhong University of Science and TechnologyDepartment of Neurology, Peking University Third HospitalBeijing Tian Tan Hospital, Capital Medical UniversityThe First Affiliated Hospital of Harbin Medical UniversityBeijing Ji Shui Tan HospitalDepartment of Neurology, Shanghai Tongji Hospital, Tongji University School of MedicineAstraZeneca R&DAstraZeneca R&DAstraZeneca R&DAstraZeneca R&D GothenburgJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht UniversityDepartment of Cardiology, China PLA General HospitalBeijing Tian Tan Hospital, Capital Medical UniversityAbstract Background The beneficial effect of statins on atherosclerosis and cardiovascular outcomes has been well established. The Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin (METEOR) global study demonstrated that a 2-year orally administered treatment with rosuvastatin 40 mg daily significantly slowed the progression of carotid intima-media thickness (CIMT) compared to placebo. The current METEOR-China study is designed to evaluate the effect of rosuvastatin 20 mg daily versus placebo on the progression of atherosclerosis measured by CIMT in asymptomatic Chinese subjects. Methods This is a phase 3, randomised, double-blind, placebo-controlled, multicentre parallel-group study. Asymptomatic Chinese subjects with a 10-year ischaemic cardiovascular disease (ICVD) risk < 10% will be recruited at 25 study sites. They will be treated with rosuvastatin 20 mg or placebo for 104 weeks. The primary endpoint is the annualised rate of change in CIMT measured by B-mode ultrasonography. Secondary endpoints include the annualised rate of change in CIMT at three different sections of the carotid artery and changes in the serum lipid profile. Safety parameters will also be assessed. Conclusion The study will evaluate whether rosuvastatin 20 mg slows the progression of CIMT in asymptomatic Chinese subjects at low risk of ICVD. Trial registration ClinicalTrials.gov NCT02546323 . Registered on September 10, 2015http://link.springer.com/article/10.1186/s13063-020-04741-0ChineseMETEOR-ChinaStudy designSubclinical atherosclerosisRosuvastatinStatin |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yilong Wang Anxin Wang Hongwei Li Zhanquan Li Bo Hu Xiaogang Li Huaguang Zheng Lu Fu Hongtao Hu Zhiyu Nie Yulin Qin Bilian Zhao Di Wei Björn W. Karlson Michiel L. Bots Yundai Chen Yongjun Wang |
spellingShingle |
Yilong Wang Anxin Wang Hongwei Li Zhanquan Li Bo Hu Xiaogang Li Huaguang Zheng Lu Fu Hongtao Hu Zhiyu Nie Yulin Qin Bilian Zhao Di Wei Björn W. Karlson Michiel L. Bots Yundai Chen Yongjun Wang Measuring effects on intima-media thickness: an evaluation of rosuvastatin in Chinese subjects with subclinical atherosclerosis—design, rationale, and methodology of the METEOR-China study Trials Chinese METEOR-China Study design Subclinical atherosclerosis Rosuvastatin Statin |
author_facet |
Yilong Wang Anxin Wang Hongwei Li Zhanquan Li Bo Hu Xiaogang Li Huaguang Zheng Lu Fu Hongtao Hu Zhiyu Nie Yulin Qin Bilian Zhao Di Wei Björn W. Karlson Michiel L. Bots Yundai Chen Yongjun Wang |
author_sort |
Yilong Wang |
title |
Measuring effects on intima-media thickness: an evaluation of rosuvastatin in Chinese subjects with subclinical atherosclerosis—design, rationale, and methodology of the METEOR-China study |
title_short |
Measuring effects on intima-media thickness: an evaluation of rosuvastatin in Chinese subjects with subclinical atherosclerosis—design, rationale, and methodology of the METEOR-China study |
title_full |
Measuring effects on intima-media thickness: an evaluation of rosuvastatin in Chinese subjects with subclinical atherosclerosis—design, rationale, and methodology of the METEOR-China study |
title_fullStr |
Measuring effects on intima-media thickness: an evaluation of rosuvastatin in Chinese subjects with subclinical atherosclerosis—design, rationale, and methodology of the METEOR-China study |
title_full_unstemmed |
Measuring effects on intima-media thickness: an evaluation of rosuvastatin in Chinese subjects with subclinical atherosclerosis—design, rationale, and methodology of the METEOR-China study |
title_sort |
measuring effects on intima-media thickness: an evaluation of rosuvastatin in chinese subjects with subclinical atherosclerosis—design, rationale, and methodology of the meteor-china study |
publisher |
BMC |
series |
Trials |
issn |
1745-6215 |
publishDate |
2020-11-01 |
description |
Abstract Background The beneficial effect of statins on atherosclerosis and cardiovascular outcomes has been well established. The Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin (METEOR) global study demonstrated that a 2-year orally administered treatment with rosuvastatin 40 mg daily significantly slowed the progression of carotid intima-media thickness (CIMT) compared to placebo. The current METEOR-China study is designed to evaluate the effect of rosuvastatin 20 mg daily versus placebo on the progression of atherosclerosis measured by CIMT in asymptomatic Chinese subjects. Methods This is a phase 3, randomised, double-blind, placebo-controlled, multicentre parallel-group study. Asymptomatic Chinese subjects with a 10-year ischaemic cardiovascular disease (ICVD) risk < 10% will be recruited at 25 study sites. They will be treated with rosuvastatin 20 mg or placebo for 104 weeks. The primary endpoint is the annualised rate of change in CIMT measured by B-mode ultrasonography. Secondary endpoints include the annualised rate of change in CIMT at three different sections of the carotid artery and changes in the serum lipid profile. Safety parameters will also be assessed. Conclusion The study will evaluate whether rosuvastatin 20 mg slows the progression of CIMT in asymptomatic Chinese subjects at low risk of ICVD. Trial registration ClinicalTrials.gov NCT02546323 . Registered on September 10, 2015 |
topic |
Chinese METEOR-China Study design Subclinical atherosclerosis Rosuvastatin Statin |
url |
http://link.springer.com/article/10.1186/s13063-020-04741-0 |
work_keys_str_mv |
AT yilongwang measuringeffectsonintimamediathicknessanevaluationofrosuvastatininchinesesubjectswithsubclinicalatherosclerosisdesignrationaleandmethodologyofthemeteorchinastudy AT anxinwang measuringeffectsonintimamediathicknessanevaluationofrosuvastatininchinesesubjectswithsubclinicalatherosclerosisdesignrationaleandmethodologyofthemeteorchinastudy AT hongweili measuringeffectsonintimamediathicknessanevaluationofrosuvastatininchinesesubjectswithsubclinicalatherosclerosisdesignrationaleandmethodologyofthemeteorchinastudy AT zhanquanli measuringeffectsonintimamediathicknessanevaluationofrosuvastatininchinesesubjectswithsubclinicalatherosclerosisdesignrationaleandmethodologyofthemeteorchinastudy AT bohu measuringeffectsonintimamediathicknessanevaluationofrosuvastatininchinesesubjectswithsubclinicalatherosclerosisdesignrationaleandmethodologyofthemeteorchinastudy AT xiaogangli measuringeffectsonintimamediathicknessanevaluationofrosuvastatininchinesesubjectswithsubclinicalatherosclerosisdesignrationaleandmethodologyofthemeteorchinastudy AT huaguangzheng measuringeffectsonintimamediathicknessanevaluationofrosuvastatininchinesesubjectswithsubclinicalatherosclerosisdesignrationaleandmethodologyofthemeteorchinastudy AT lufu measuringeffectsonintimamediathicknessanevaluationofrosuvastatininchinesesubjectswithsubclinicalatherosclerosisdesignrationaleandmethodologyofthemeteorchinastudy AT hongtaohu measuringeffectsonintimamediathicknessanevaluationofrosuvastatininchinesesubjectswithsubclinicalatherosclerosisdesignrationaleandmethodologyofthemeteorchinastudy AT zhiyunie measuringeffectsonintimamediathicknessanevaluationofrosuvastatininchinesesubjectswithsubclinicalatherosclerosisdesignrationaleandmethodologyofthemeteorchinastudy AT yulinqin measuringeffectsonintimamediathicknessanevaluationofrosuvastatininchinesesubjectswithsubclinicalatherosclerosisdesignrationaleandmethodologyofthemeteorchinastudy AT bilianzhao measuringeffectsonintimamediathicknessanevaluationofrosuvastatininchinesesubjectswithsubclinicalatherosclerosisdesignrationaleandmethodologyofthemeteorchinastudy AT diwei measuringeffectsonintimamediathicknessanevaluationofrosuvastatininchinesesubjectswithsubclinicalatherosclerosisdesignrationaleandmethodologyofthemeteorchinastudy AT bjornwkarlson measuringeffectsonintimamediathicknessanevaluationofrosuvastatininchinesesubjectswithsubclinicalatherosclerosisdesignrationaleandmethodologyofthemeteorchinastudy AT michiellbots measuringeffectsonintimamediathicknessanevaluationofrosuvastatininchinesesubjectswithsubclinicalatherosclerosisdesignrationaleandmethodologyofthemeteorchinastudy AT yundaichen measuringeffectsonintimamediathicknessanevaluationofrosuvastatininchinesesubjectswithsubclinicalatherosclerosisdesignrationaleandmethodologyofthemeteorchinastudy AT yongjunwang measuringeffectsonintimamediathicknessanevaluationofrosuvastatininchinesesubjectswithsubclinicalatherosclerosisdesignrationaleandmethodologyofthemeteorchinastudy |
_version_ |
1724420981536063488 |